Deloitte’s Path to 21st Century Cures A Call to Action

Our country has had a strong commitment to life sciences research and development R&D for new treatments and cures. For the past two decades, the U.S. was the world’s leading funder and life sciences innovator - providing up to 70 to 80 percent of global life sciences R&D funding. In recent years, the U.S. has had a major decline in its global R&D competitiveness. Other nations, especially those in the Asia–Oceania region, are more actively competing and investing in various elements of the value chain. The U.S. life sciences industry faces unprecedented challenges with expiry of blockbuster patents, slowing pipelines, soaring R&D costs, increasing pricing pressure from payers, growing market share for generic pharmaceuticals, and tightened scrutiny by regulators over drug safety.

Spotlight

IMS Health

IMS Health has now merged with Quintiles. Visit our new website for more information www.quintilesims.com IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

OTHER WHITEPAPERS
news image

The Promise of Robotic Process Automation and Artificial Intelligence in Revenue Cycle Management

whitePaper | August 25, 2022

The revenue cycle process has a long and cumbersome history that continues to become more complex as policies, payer relationships, and patient expectations evolve.

Read More
news image

How Social Determinants of Health Influence Patient Outcomes and How Clinicians Can Help

whitePaper | December 19, 2022

Envision Healthcare is one of the nation's leading medical groups, delivering care when and where it's needed most. Operating in more than 650 facilities, Envision provides care mainly in the areas of emergency medicine, hospital medicine, anesthesiology, radiology, trauma surgery and neonatology.

Read More
news image

HEALTHCARE COMPLIANCE IN CHANGING REGULATORY LANDSCAPE

whitePaper | July 8, 2022

Before the onset of the coronavirus pandemic, forces at the federal level were in motion to transform the healthcare industry from a closed to a more open system.

Read More
news image

AI Powered Business Intelligence for Life Science Leaders: Save Time, Drive Adoption and Scale Faster

whitePaper | January 10, 2023

Life sciences business leaders around the globe agree that timely information and business insights hold the key to competing successfully in an increasingly digital world.

Read More
news image

Healthcare Marketers Speak Out

whitePaper | November 25, 2022

Healthcare marketers are optimistic about the future and driving innovation by accelerating and prioritizing digital-first strategies.

Read More
news image

Employer Health Benefits

whitePaper | October 27, 2022

In 2022, the average annual premiums for employer sponsored health insurance are $7,911 for single coverage and $22,463 for family coverage.

Read More

Spotlight

IMS Health

IMS Health has now merged with Quintiles. Visit our new website for more information www.quintilesims.com IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Events